Alnylam Pharmaceuticals, Inc. - Common Stock (NQ:ALNY)
Price and Volume
Detailed Quote| Volume | 3,589,978 |
| Open | 159.17 |
| Bid (Size) | 164.80 (80) |
| Ask (Size) | 165.91 (40) |
| Prev. Close | 156.65 |
| Today's Range | 158.82 - 168.35 |
| 52wk Range | 149.18 - 479.79 |
| Shares Outstanding | 118,847,693 |
| Dividend Yield | N/A |
Top News
More News
Alnylam Pharmaceuticals (NASDAQ:ALNY) Emerges as a Decent Value Stock ↗
November 12, 2026
Via Chartmill
Performance
52-Week Range
65.6% below 52-week high
165.04
149.1852W Low
479.7952W High
1 Week
2.0% below 1-week high
149.181W Low
168.351W High
Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY) traded between $149.18 and $479.79 over the past 52 weeks and last traded at $165.04, 65.6% below its 52-week high. Over the past week it ranged between $149.18 and $168.35.
Past 12 Months
+5.4%
-26.5%
-27.8%
-42.5%
-58.8%
-63.6%
1W
+$8.43
1M
-$59.43
3M
-$63.61
6M
-$121.94
YTD
-$235.13
1Y
-$288.93
ALNY was -63.6% over the past year, -42.5% over six months, -58.8% year to date, +5.4% in the last week.
12 Months vs Market
ALNY
-63.6%
DIA
+10.2%
SPY
+12.3%
QQQ
+11.8%
IWM
+17.2%
Over the past 12 months ALNY returned -63.6% versus DIA (Dow) +10.2%, SPY (S&P 500) +12.3%, QQQ (Nasdaq 100) +11.8% and IWM (Russell 2000) +17.2%.
Volume & Liquidity
1.76× 3-mo avg
Today 3,589,978
3-mo avg 2.0M
1W
3.2M
1M
3.0M
3M
2.0M
6M
1.8M
YTD
1.6M
1Y
1.6M
ALNY most recently traded 3,589,978 shares against a 3-month average daily volume of 2.0M.
More News
Read More
3 Nasdaq-100 Stocks That Can Double, According to Wall Street ↗
November 04, 2026
Via The Motley Fool
Topics
Artificial Intelligence
Top US Stock Gainers and Losers for Oct. 29, 2026 ↗
October 29, 2026
Via Chartmill
Alnylam (ALNY) Q3 2026 Earnings Call Transcript ↗
October 29, 2026
Via The Motley Fool
Topics
Earnings
Alnylam Pharmaceuticals Q3 Earnings Call Highlights ↗
October 29, 2026
Via MarketBeat
Topics
Earnings
Premarket Gainers and Losers on Oct. 29, 2026 ↗
October 29, 2026
Via Chartmill
Via MarketBeat
Alnylam vs. Ionis: Here's the Better Bad-News Buy ↗
October 10, 2026
Via The Motley Fool
18 of 21 Analysts Still Think Alnylam Stock Is a Buy. Here's Why They're Right. ↗
September 28, 2026
Via The Motley Fool
Alnylam Highlights AMVUTTRA Momentum, Resets 2026 TTR Revenue Outlook ↗
September 20, 2026
Via MarketBeat
Alnylam’s Zilebesiran Targets Twice-Yearly Blood Pressure Control in ZENITH Trial ↗
September 19, 2026
Via MarketBeat
Topics
Death
Frequently Asked Questions
Is Alnylam Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Alnylam Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Alnylam Pharmaceuticals, Inc. - Common Stock trade on?
Alnylam Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Alnylam Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Alnylam Pharmaceuticals, Inc. - Common Stock is ALNY on the Nasdaq Stock Market
What is the current price of Alnylam Pharmaceuticals, Inc. - Common Stock?
The current price of Alnylam Pharmaceuticals, Inc. - Common Stock is 165.04
When was Alnylam Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Alnylam Pharmaceuticals, Inc. - Common Stock was at 11/13/26 04:00 PM ET
What is the market capitalization of Alnylam Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Alnylam Pharmaceuticals, Inc. - Common Stock is 19.61B
How many shares of Alnylam Pharmaceuticals, Inc. - Common Stock are outstanding?
Alnylam Pharmaceuticals, Inc. - Common Stock has 20B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>